Dosidal · Belgium
Lexotan 6 mg
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Belgium |
|---|---|
| Record | be:presentation:cti:054494-01 (version 1) |
| Level | presentation |
| Pack code | be-cnk (Belgian national): 0052811 |
| Identifiers | be-cti-extended: 054494-01 be-cnk: 0052811 be-authorisation: BE054494 |
| Source authority | FAMHP |
| Read date | 2026-11-15T03:58:09Z |
| authorisation status | amp_status: AUTHORIZED ampp_status: AUTHORIZED commercialised_now: False lifecycle: current period_from: 1973-11-29 supply_problem_now: False state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| controlled status | state: unknown |
| identity | amp_code: SAM054494-00 atc: N05BA08 authorisation_number: BE054494 cti_extended: 054494-01 form: Tablet holder: Cheplapharm Arzneimittel medicine_type: ALLOPATHIC name: Lexotan 6 mg pack: 20 parallel_circuit: 0 parallel_import: False substances: strength: 6.0000 mg substance: Bromazepam state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| pack product code | cnk_public: 0052811 fmd_in_scope: True note: no FMD product code in SAM for this pack: the maker's GTIN is not published state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| prescription class | as_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006 class: prescription delivery_modus: M1 state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53JIii01Z-nLV7PrYjaLtZt9x9SbZ47OPIlGsNAc3Do6XFpjaG-orRKmtLSPYw-2Q6WJH32NShtnKwmc1h9D3wygVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:054494-01 · Related records in other markets · Dosidal